# Evolutionary Genomics, Inc. (FNAM)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/FNAM/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2022 | $ 0 | $ -2.07M | $ -716.0K | $ 3.74M | $ -5.59M |
| 2021 | $ 0 | $ -3.32M | $ -1.88M | $ 3.74M | $ -4.40M |
| 2020 | $ 0 | $ -2.18M | $ -2.93M | $ 2.25M | $ -1.83M |
| 2019 | $ 158.4K | $ -1.02M | $ -808.0K | $ 0 | $ -333.7K |
| 2018 | $ 151.6K | $ -1.45M | $ -989.0K | $ 0 | $ 403.6K |
| 2017 | $ 0 | $ -718.1K | $ -1.59M | $ 0 | $ 1.40M |
| 2016 | $ 304.9K | $ -1.58M | $ -1.66M | $ 0 | $ 1.84M |
| 2015 | $ 461.9K | $ -401.6K | $ -828.4K | $ 0 | $ 2.92M |
| 2014 | $ 344.9K | $ -38.3K | $ -267.7K | $ 0 | $ -13.7K |
| 2013 | $ 0 | $ -27.4K | $ -18.7K | $ 0 | $ -77.2K |
| 2012 | $ 0 | $ -24.6K | $ -20.7K | $ 0 | $ -62.6K |
| 2011 | $ 0 | $ -25.5K | $ -39.3K | $ 0 | $ -48.5K |
| 2010 | $ 0 | $ -35.6K | $ -39.0K | $ 0 | $ -31.2K |
| 2009 | $ 0 | $ -1.0K | $ 114 | $ 0 | $ -7.6K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.67 |
| Liabilities / Eq | -1.42 |
| Current Ratio | 3.92 |

## Other views

- [Metrics](https://sponda.capital/en/FNAM.md)
- [Charts](https://sponda.capital/en/FNAM/charts.md)
- [Compare](https://sponda.capital/en/FNAM/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.